Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10929591rdf:typepubmed:Citationlld:pubmed
pubmed-article:10929591lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10929591lifeskim:mentionsumls-concept:C0079773lld:lifeskim
pubmed-article:10929591lifeskim:mentionsumls-concept:C0699748lld:lifeskim
pubmed-article:10929591pubmed:issue7lld:pubmed
pubmed-article:10929591pubmed:dateCreated2000-11-8lld:pubmed
pubmed-article:10929591pubmed:abstractTextCutaneous T-cell lymphoma (CTCL) is a malignancy of a distinctive subset of T-helper cells designated "cutaneous T cells" because of their central role in the normal functioning of the skin immune system. Guided by selective adhesion molecules, activated/memory T cells of the skin immune system normally circulate among the skin, lymph nodes, and peripheral blood. Thus, a better understanding of the skin immune system, which normally functions to provide immunosurveillance against cutaneous pathogens and other insults, has led to a better understanding of the clinical spectrum, pathogenesis, staging, and management of CTCL. This article describes the major subtypes of CTCL and provides an update on the pathogenesis and treatment of this lymphoma.lld:pubmed
pubmed-article:10929591pubmed:languageenglld:pubmed
pubmed-article:10929591pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10929591pubmed:citationSubsetIMlld:pubmed
pubmed-article:10929591pubmed:statusMEDLINElld:pubmed
pubmed-article:10929591pubmed:monthJullld:pubmed
pubmed-article:10929591pubmed:issn0890-9091lld:pubmed
pubmed-article:10929591pubmed:authorpubmed-author:EdelsonR LRLlld:pubmed
pubmed-article:10929591pubmed:authorpubmed-author:GirardiMMlld:pubmed
pubmed-article:10929591pubmed:issnTypePrintlld:pubmed
pubmed-article:10929591pubmed:volume14lld:pubmed
pubmed-article:10929591pubmed:ownerNLMlld:pubmed
pubmed-article:10929591pubmed:authorsCompleteYlld:pubmed
pubmed-article:10929591pubmed:pagination1061-70; discussion 1070-4, 1076lld:pubmed
pubmed-article:10929591pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:meshHeadingpubmed-meshheading:10929591...lld:pubmed
pubmed-article:10929591pubmed:year2000lld:pubmed
pubmed-article:10929591pubmed:articleTitleCutaneous T-cell lymphoma: pathogenesis and treatment.lld:pubmed
pubmed-article:10929591pubmed:affiliationDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.lld:pubmed
pubmed-article:10929591pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10929591pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10929591lld:pubmed